Rhythm Pharmaceuticals (RYTM) Current Deferred Revenue (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Current Deferred Revenue of $48000.0 for Q1 2026, down 75.26% quarter-over-quarter from $194000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Current Deferred Revenue (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Current Deferred Revenue for 9 consecutive years, with $48000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $48000.0; the TTM figure through Mar 2026 stood at $48000.0 (changed N/A YoY), while the FY2025 annual figure was $194000.0, down 84.91% from the prior year.
- Current Deferred Revenue slipped to $48000.0 in Q1 2026 per RYTM's latest filing, from $194000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $9.4 million in Q1 2022 and bottomed at $48000.0 in Q1 2026.
- Historically, Current Deferred Revenue has averaged $1.8 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue changed 0.0% — and 2025, when it slumped 84.91%.
- Rhythm Pharmaceuticals' Current Deferred Revenue stood at $1.4 million in 2022, then dropped by 10.32% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then plunged by 84.91% to $194000.0 in 2025, then sank by 75.26% to $48000.0 in 2026.
- Business Quant data shows RYTM's Current Deferred Revenue at $48000.0 in Q1 2026, $194000.0 in Q4 2025, and $1.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 9.44 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Jun 30, 2018 | 86,000.00 |
| Mar 31, 2018 | 85,000.00 |
| Dec 31, 2017 | 83,000.00 |
| Sep 30, 2017 | 81,000.00 |
| Dec 31, 2016 | 76,000.00 |